Article | February 24, 2022

Back To Basics: 505(b)(2) FAQs Part 3: Regulatory Strategies

Source: Premier Consulting

By Angela Drew, Ph.D., Product Ideation Consultant

iStock-1288116976-regulatory-compliance

As the 505(b)(2) expert, Premier Consulting is frequently asked questions about how to get a product approved via the 505(b)(2) regulatory pathway and if this pathway is appropriate. Given the growing popularity of the 505(b)(2) pathway for approval of repurposed, reformulated, or unapproved-marketed products, we thought it would be worth providing a refresher. Here is Part 3 in our series of frequently asked questions (FAQs). Stay tuned to this blog for more FAQs and Premier Consulting’s responses in the coming weeks.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online